FindTrial
Sign In

comparison of two potencies of kali bromatum in the treatment of acne (pimples) in adults

To Study The Role of Kali Bromatum in Centisimal and Fifty Millesimal Potency in Homoeopathic Management of Acne Vulgaris in Adult Age Group- An Experimental Comparative Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109827
Enrollment
233
Registered
2026-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: kali bromatum in centesimal potency: Group A Intervention Group (Centesimal Potency) Patients will receive Kali bromatum 30C potency. Dose: 4 globules per dose Route of administration
1 teaspoon per dose Route of administration: Oral Frequency: Once daily for 21 days (continuous dosing in each cycle) One cycle: 21 days Repetition: Potency may be increased sequentially (LM2, LM3, et

Sponsors

Pallavi Vilas sonawane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient giving written consent . patient in adult age group in any gender will be eligible

Exclusion criteria

Exclusion criteria: patient below 18 yrs age. patient who dose not give consent. female patient who is pregnant and lactating.

Design outcomes

Primary

MeasureTime frame
GAGS ScaleTimepoint: 15 days—

Secondary

MeasureTime frame
lifestyle improvementTimepoint: 15 days—

Countries

India

Contacts

Public ContactPallavi Vilas Sonawane

Guru Mishri Homoeopathic Medical College

pg@gurumishrihmc.edu.in9021717357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026